Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

EZ-Tet-pLKO-Puro Citations (15)

Originally described in: A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
Frank SB, Schulz VV, Miranti CK BMC Biotechnol. 2017 Feb 28;17(1):24. doi: 10.1186/s12896-017-0341-x.
PubMed Journal

Articles Citing EZ-Tet-pLKO-Puro

Articles
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P, Ciccarelli FD. Nat Commun. 2019 Jul 15;10(1):3101. doi: 10.1038/s41467-019-10898-3. PubMed
Androgen receptor-induced integrin alpha6beta1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Nollet EA, Cardo-Vila M, Ganguly SS, Tran JD, Schulz VV, Cress A, Corey E, Miranti CK. Oncogene. 2020 Jul;39(31):5390-5404. doi: 10.1038/s41388-020-1370-9. Epub 2020 Jun 21. PubMed
Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Ghosh M, Saha S, Bettke J, Nagar R, Parrales A, Iwakuma T, van der Velden AWM, Martinez LA. Cancer Cell. 2021 Apr 12;39(4):494-508.e5. doi: 10.1016/j.ccell.2021.01.003. Epub 2021 Feb 4. PubMed
Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas. Norton JP, Augert A, Eastwood E, Basom R, Rudin CM, MacPherson D. Genes Dev. 2021 Jun;35(11-12):870-887. doi: 10.1101/gad.348316.121. Epub 2021 May 20. PubMed
Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells. La T, Chen S, Guo T, Zhao XH, Teng L, Li D, Carnell M, Zhang YY, Feng YC, Cole N, Brown AC, Zhang D, Dong Q, Wang JY, Cao H, Liu T, Thorne RF, Shao FM, Zhang XD, Jin L. Theranostics. 2021 Sep 21;11(19):9605-9622. doi: 10.7150/thno.63763. eCollection 2021. PubMed
DUSP4 Inactivation Leads to Reduced Extracellular SignalRegulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells. Kamada H, Yasuhira S, Shibazaki M, Amano H, Maesawa C. J Invest Dermatol. 2022 Sep;142(9):2499-2507.e6. doi: 10.1016/j.jid.2022.02.007. Epub 2022 Feb 19. PubMed
A commercial ARHGEF17/TEM4 antibody cross-reacts with Nuclear Mitotic Apparatus protein 1 (NuMA). Prifti DK, Lauzier A, Elowe S. PLoS One. 2022 Jul 1;17(7):e0268848. doi: 10.1371/journal.pone.0268848. eCollection 2022. PubMed
A novel binding site on the cryptic intervening domain is a motif-dependent regulator of O-GlcNAc transferase. Blankenship C, Xie J, Benz C, Wang A, Ivarsson Y, Jiang J. Res Sq. 2023 Feb 2:rs.3.rs-2531412. doi: 10.21203/rs.3.rs-2531412/v1. Preprint. PubMed
Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle. Rajabian N, Ikhapoh I, Shahini S, Choudhury D, Thiyagarajan R, Shahini A, Kulczyk J, Breed K, Saha S, Mohamed MA, Udin SB, Stablewski A, Seldeen K, Troen BR, Personius K, Andreadis ST. Nat Commun. 2023 Feb 16;14(1):886. doi: 10.1038/s41467-023-36483-3. PubMed
Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53. Hu CW, Wang A, Fan D, Worth M, Chen Z, Huang J, Xie J, Macdonald J, Li L, Jiang J. Res Sq [Preprint]. 2023 Mar 20:rs.3.rs-2709128. doi: 10.21203/rs.3.rs-2709128/v1. PubMed
Proteomic analysis reveals microvesicles containing NAMPT as mediators of radioresistance in glioma. Panizza E, Regalado BD, Wang F, Nakano I, Vacanti NM, Cerione RA, Antonyak MA. Life Sci Alliance. 2023 Apr 10;6(6):e202201680. doi: 10.26508/lsa.202201680. Print 2023 Jun. PubMed
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer. Gonthier K, Weidmann C, Berthiaume L, Jobin C, Lacouture A, Lafront C, Harvey M, Neveu B, Loehr J, Bergeron A, Fradet Y, Lacombe L, Riopel J, Latulippe E, Atallah C, Shum M, Lambert JP, Pouliot F, Pelletier M, Audet-Walsh E. Mol Oncol. 2023 Oct;17(10):2109-2125. doi: 10.1002/1878-0261.13441. Epub 2023 Jul 19. PubMed
The Septin Cytoskeleton is Required for Plasma Membrane Repair. Prislusky MI, Lam JG, Contreras VR, Ng M, Chamberlain M, Fields M, Zhang X, Amer AO, Seveau S. bioRxiv. 2023 Jul 12:2023.07.12.548547. doi: 10.1101/2023.07.12.548547. Preprint. PubMed
A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway. Herron RS, Kunisky AK, Madden JR, Anyaeche VI, Maung MZ, Hwang HW. Elife. 2023 Sep 4;12:e85036. doi: 10.7554/eLife.85036. PubMed
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Juarez D, Buono R, Matulis SM, Gupta VA, Duong M, Yudiono J, Paul M, Mallya S, Diep G, Hsin P, Lu A, Suh SM, Dong VM, Roberts AW, Leverson JD, Jalaluddin M, Liu Z, Bueno OF, Boise LH, Fruman DA. Cancer Res Commun. 2023 Dec 8;3(12):2497-2509. doi: 10.1158/2767-9764.CRC-23-0350. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.